MedPath

Assessment of the impact of a clinical pharmacist compared to standard care in improving quality use of medicines, patient adherence and reducing hospital readmissions in patients diagnosed with acute coronary syndrome

Not Applicable
Recruiting
Conditions
Acute Coronary Syndrome
Registration Number
SLCTR/2019/039
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Male and female patients above 18 years of age who are diagnosed and managed as ACS by the medical team will be considered as the study population in this study

Exclusion Criteria

Patients who refuse to participate
Patients who are diagnosed with psychological disorders
Patients who are younger than 18 years
Patients who are pregnant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Number of hospital readmissions due to acute coronary syndrome related issues during the study period [At the end of the followup period (six months after discharge)]<br> 2) Changes in medication adherence. (Patients medication adherence will be compared between the time of recruitment and end of study at six months after discharge using a validated tool (Brief Medication Questionnaire)<br> [ ]<br>
Secondary Outcome Measures
NameTimeMethod
Number of Drug related problems [ At the end of the followup period (six months after discharge)]<br> Number of adverse drug reactions during the study period [ At the end of the followup period (six months after discharge)]<br> Cost effectiveness of clinical pharmacist intervention [ At the end of the followup period (six months after discharge)]<br>
© Copyright 2025. All Rights Reserved by MedPath